Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00393-017-0292-6
Published Online: 2017-03-21
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bae, S.-C.
Lee, Y. H.
License valid from 2017-03-21
